Halozyme Therapeutics, Inc. (HALO) Earnings
NASDAQ·Healthcare·Biotechnology
$129.36
-1.14%
Mkt Cap $14.86B
EPS — Estimate vs Actual
Mkt Cap
$14.86B
P/E
51.95
Fwd P/E
7.47
P/S
10.64
Rev TTM
—
EPS TTM
$2.49
NASDAQ·Healthcare·Biotechnology
$129.36
-1.14%
Mkt Cap $14.86B
Mkt Cap
$14.86B
P/E
51.95
Fwd P/E
7.47
P/S
10.64
Rev TTM
—
EPS TTM
$2.49